Immunodeficiency Clinic UHN: Courage Lives Here
  • Home
  • Clinic
    • Clinic Overview
    • Mission Statement
    • Clinic Services
    • Clinic Staff
    • Contact & Directions
    • The Clinic Pharmacy
  • Patient
    • Patient Overview
    • Your First Visit
    • A Guide To Accessing Treatment
    • Medication Payment Assistance in Ontario
      • Private Insurance
      • Ontario Drug Benefit Program (ODB)
      • Interim Federal Health (IFHP)
      • Other Systems
      • Appendix 1
      • Appendix 2
    • Frequently Asked Questions on taking Antiretrovirals
      • Why take antiretrovirals?
      • Why is it important to take medications regularly?
      • Why do certain drugs have to be taken with food and others taken on an empty stomach?
      • What if you have side effects?
      • Should you lower your drug dose if you are having side effects?
      • Is it safe to take antiretrovirals with other medications?
      • Is it safe to use alcohol or recreational drugs while you are on antiretroviral therapy?
      • Why should medications be stored under specific conditions?
      • What are some suggestions and tips to help make taking medications easier?
      • Who should you tell if you are having problems?
      • How can you get support and encouragement?
      • Credits
    • Medication Fact Sheets
    • Glossary of Terms
  • Drug Information
    • Drug Information Home
    • Drug Interaction Tables
    • Antiretroviral Interactions with Chemotherapy Regimens
    • Additional Information for Healthcare Professionals
    • Medication Fact Sheets
    • Drug Reimbursement Information
  • Research
    • Who We Are
    • Clinical Trials
      • Treatment Naive Individuals
      • Treatment Experienced Individuals
      • Hepatitis Co-infection
      • Herpes Co-infection
      • Immunization / Vaccine
      • Nutrition
      • Women
      • Anal Cancer
      • Pharmacokinetic Studies
      • OHTN Cohort Study
      • Other Studies
    • Frequently Asked Questions
    • Posters and Publications
    • Donations
    • How to Stay in the Loop
  • Residency
    • HIV Pharmacy Specialty Residency Program
    • HIV Advanced (Year 2) Residency Program Manual
      • 1. Residency Program Information
      • 2. Policies and Procedures
      • 3. RESIDENCY ADVISORY COMMITTEE
      • 4. PRESENTATIONS
      • 5. ROTATION DESCRIPTIONS
      • 6. Assessment Information
      • 7. TOOLS AND RESOURCES
      • 8. CPRB ACCREDITATION STANDARDS
      • 9. YEARLY SCHEDULES
      • 10. ORIENTATION
        • Case Presentation
        • Goals and Objectives
        • Evaluation Case Presentation
        • Evidence-based Pharmacotherapy Presentations
        • Format of Resident’s Presentations
        • Guidelines for the Resident’s Research Project
        • Guidelines on Making Poster Presentations
        • Guidelines on Manuscript Preparation
        • Guidelines on Presentation Skills
    • Immunodeficiency Clinic Resident’s Training Package
  • Pharmacy Org
    • CHAP
    • Ontario HIV Professional Specialty Group

Women

Antiretroviral Trials

Currently Enrolling

The ProSPAR Study: Progesterone Supplementation for HIV-positive Pregnant women on Anti-Retrovirals

Sponsor: CIHR, CANFAR

Contact: Rosemarie Clarke or Adri D’Aquila
(416)340-4800 ext. 6723 or (416)340-4800 ext. 8170

Not Enrolling, but Ongoing


Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women
Sponsor: University of California, Los Angeles, Merck, Case Western Reserve
Contact: Rosemarie Clarke
(416) 340-4800 ext. 6723 or
Adriana D’Aquila
(416) 340-4800 ext. 8170

Completed Studies with Results

Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS)


A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women
(ARIA, ING117172)



Phase II Study of Raltegravir as Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Based Antiretroviral Therapy in Women With Fat Accumulation (CARE 001)


Tweet
Immunodeficiancy Clinic Drug Therapy Guide: Interactive Application

Research Menu


  • Who we Are
  • Clinical Trials
  • Posters and Publications
  • FAQ
  • How to Stay in the Loop

Contact Us

Facebook

Immunodeficiency Clinic

4 weeks ago

Immunodeficiency Clinic

Great news! ...

Moderna vaccine gets approval boosting Canada’s fight against COVID-19

www.thestar.com

Health Canada has approved a second COVID-19 vaccine, giving the green-light to Moderna to distribute its two-step inoculation against the deadly dise...
View on Facebook
·Share

Share on FacebookShare on TwitterShare on Linked InShare by Email

Immunodeficiency Clinic

1 month ago

Immunodeficiency Clinic

CLINIC CLOSURE:

Please be advised that the Immunodeficiency Clinic will be closed as of Thursday December 24th for the holiday season. We will be returning to our normal hours (8am to 4pm) on Monday January 4th, 2021.

The Clinic Pharmacy will also be closed for the same dates. So, if you need to pick up medication, you will need to do so before 4pm on Wednesday December 23rd.

The Clinic staff would like to wish everyone a happy holiday season, and we hope that you and your families stay safe during these strange and unprecedented times.

We will see you in 2021!
...

View on Facebook
·Share

Share on FacebookShare on TwitterShare on Linked InShare by Email

Immunodeficiency Clinic

1 month ago

Immunodeficiency Clinic

Health Canada approves first vaccine for COVID-19 - thestar.com www.thestar.com/politics/federal/2020/12/09/health-canada-approves-first-vaccine-for-covid-19.html ...

Health Canada approves first vaccine for COVID-19

www.thestar.com

Health Canada announced Wednesday it has approved the first COVID-19 vaccine for distribution and use in Canada, a historic offensive move to defeat t...
View on Facebook
·Share

Share on FacebookShare on TwitterShare on Linked InShare by Email

Twitter

Tweets by @HivClinic
  • Privacy Policy
  • Terms & Conditions

  © 2021 Immunodeficiency Clinic, 585 University Avenue, Toronto, Ontario